BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1286313)

  • 21. Evaluation of adjuvant therapy after surgery for primary carcinoma of the fallopian tube.
    Klein M; Rosen A; Lahousen M; Graf A; Vavra N; Pakisch B; Poschauko J; Beck A; Kucera H
    Arch Gynecol Obstet; 1994; 255(1):19-24. PubMed ID: 8042874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary fallopian tube carcinoma: a clinicopathologic study of 10 cases.
    Konishi Y; Sato H; Fujimoto T; Tanaka H; Takahashi O; Tanaka T
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):260-1. PubMed ID: 17574324
    [No Abstract]   [Full Text] [Related]  

  • 23. A 15-year overview of management and prognosis in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.
    Rosen AC; Ausch C; Hafner E; Klein M; Lahousen M; Graf AH; Reiner A
    Eur J Cancer; 1998 Oct; 34(11):1725-9. PubMed ID: 9893660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stage III malignant mixed Müllerian tumor of the fallopian tube: a case of 5-year survival after optimal debulking and adjuvant chemotherapy with paclitaxel plus carboplatin.
    Tsai CP; Ho ES; Ke YM; Hsu ST; Wang RC; Lu CH
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):294-6. PubMed ID: 22795114
    [No Abstract]   [Full Text] [Related]  

  • 25. Case report: Bone metastases from fallopian tube carcinoma.
    Courville XF; Cortés Z; Katzman PJ; Rosier RN
    Clin Orthop Relat Res; 2005 May; (434):278-81. PubMed ID: 15864065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
    Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
    Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of fallopian tube carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Morris M; Gershenson DM; Burke TW; Kavanagh JJ; Silva EG; Wharton JT
    Obstet Gynecol; 1990 Dec; 76(6):1020-4. PubMed ID: 2234710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
    Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
    Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary carcinoma of the fallopian tube.
    Podratz KC; Podczaski ES; Gaffey TA; O'Brien PC; Schray MF; Malkasian GD
    Am J Obstet Gynecol; 1986 Jun; 154(6):1319-26. PubMed ID: 3013008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recurrent metastatic fallopian tube carcinoma in pregnancy.
    Adolph A; Le T; Khan K; Biem S
    Gynecol Oncol; 2001 Apr; 81(1):110-2. PubMed ID: 11277660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
    Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
    Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary fallopian tube carcinoma: a retrospective multicenter study.
    Tulunay G; Arvas M; Demir B; Demirkiran F; Boran N; Bese T; Ozgul N; Kose MF; Kosebay D
    Eur J Gynaecol Oncol; 2004; 25(5):611-4. PubMed ID: 15493178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary fallopian tube carcinoma: clinicopathological analysis of 12 cases.
    Ou YC; Huang HY; Huang CC; Changchien CC; Tseng CW; Lin H
    Taiwan J Obstet Gynecol; 2011 Jun; 50(2):141-4. PubMed ID: 21791297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fallopian tube malignancies: A retrospective clinical pathological study of 17 cases.
    Liapis A; Bakalianou K; Mpotsa E; Salakos N; Fotiou S; Kondi-Paffiti A
    J Obstet Gynaecol; 2008 Jan; 28(1):93-5. PubMed ID: 18259909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
    Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS
    Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass.
    Scholz HS; Lax S; Tamussino KF; Benedicic C; Petru E
    Anticancer Res; 2000; 20(6C):4801-2. PubMed ID: 11205221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paclitaxel and carboplatin therapy in stage I fallopian tube carcinoma.
    Gungor T; Altundag OB; Ustunyurt E; Mollamahmutoglu L
    Int J Gynaecol Obstet; 2006 Nov; 95(2):163-4. PubMed ID: 16828094
    [No Abstract]   [Full Text] [Related]  

  • 38. Para-aortic lymphadenectomy for primary fallopian tube cancer.
    Koo YJ; Kwon YS; Lim KT; Lee KH; Shim JU; Mok JE
    Int J Gynaecol Obstet; 2011 Jan; 112(1):18-20. PubMed ID: 20887989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second-look laparotomy in carcinoma of the fallopian tube.
    Barakat RR; Rubin SC; Saigo PE; Lewis JL; Jones WB; Curtin JP
    Obstet Gynecol; 1993 Nov; 82(5):748-51. PubMed ID: 8414320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
    Lan C; Li Y; Liu J
    Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.